Novartis, Pfizer cut prices to win UK approval for cancer drugs

LONDON (Reuters) - Novartis and Pfizer have won approval for two cancer drugs to be used routinely on Britain's National Health Service after offering bigger price discounts.
Read the full story: Reuters: Health News